1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Jacobsen, N.E.
Skelton, N.J.
Fairbrother, W.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
35
3402
3417
10.1021/bi952626l
8639490
High-resolution solution structure of the EGF-like domain of heregulin-alpha.
1996
US
Science
SCIEAS
0038
0036-8075
256
1205
Identification of Heregulin, a Specific Activator of P185Erbb2
1992
10.2210/pdb1haf/pdb
pdb_00001haf
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
7129.222
HEREGULIN-ALPHA
EPIDERMAL GROWTH FACTOR-LIKE DOMAIN
1
man
polymer
NEU DIFFERENTIATION FACTOR (RAT), ACETYLCHOLINE RECEPTOR INDUCING ACTIVITY (CHICKEN), GLIAL GROWTH FACTOR (HUMAN), NEUREGULIN
no
no
SHLVKCAEKEKTFCVNGGECFMVKDLSNPSRYLCKCQPGFTGARCTENVPMKVQNQEKAEELY
SHLVKCAEKEKTFCVNGGECFMVKDLSNPSRYLCKCQPGFTGARCTENVPMKVQNQEKAEELY
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
Other
1
0
1996-07-11
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_pdbx_nmr_software.name
Y
BNL
1995-11-30
REL
1
4.5
293
K
BIOSYM TECHNOLOGIES
refinement
Discover
SER
1
n
1
SER
1
A
HIS
2
n
2
HIS
2
A
LEU
3
n
3
LEU
3
A
VAL
4
n
4
VAL
4
A
LYS
5
n
5
LYS
5
A
CYS
6
n
6
CYS
6
A
ALA
7
n
7
ALA
7
A
GLU
8
n
8
GLU
8
A
LYS
9
n
9
LYS
9
A
GLU
10
n
10
GLU
10
A
LYS
11
n
11
LYS
11
A
THR
12
n
12
THR
12
A
PHE
13
n
13
PHE
13
A
CYS
14
n
14
CYS
14
A
VAL
15
n
15
VAL
15
A
ASN
16
n
16
ASN
16
A
GLY
17
n
17
GLY
17
A
GLY
18
n
18
GLY
18
A
GLU
19
n
19
GLU
19
A
CYS
20
n
20
CYS
20
A
PHE
21
n
21
PHE
21
A
MET
22
n
22
MET
22
A
VAL
23
n
23
VAL
23
A
LYS
24
n
24
LYS
24
A
ASP
25
n
25
ASP
25
A
LEU
26
n
26
LEU
26
A
SER
27
n
27
SER
27
A
ASN
28
n
28
ASN
28
A
PRO
29
n
29
PRO
29
A
SER
30
n
30
SER
30
A
ARG
31
n
31
ARG
31
A
TYR
32
n
32
TYR
32
A
LEU
33
n
33
LEU
33
A
CYS
34
n
34
CYS
34
A
LYS
35
n
35
LYS
35
A
CYS
36
n
36
CYS
36
A
GLN
37
n
37
GLN
37
A
PRO
38
n
38
PRO
38
A
GLY
39
n
39
GLY
39
A
PHE
40
n
40
PHE
40
A
THR
41
n
41
THR
41
A
GLY
42
n
42
GLY
42
A
ALA
43
n
43
ALA
43
A
ARG
44
n
44
ARG
44
A
CYS
45
n
45
CYS
45
A
THR
46
n
46
THR
46
A
GLU
47
n
47
GLU
47
A
ASN
48
n
48
ASN
48
A
VAL
49
n
49
VAL
49
A
PRO
50
n
50
PRO
50
A
MET
51
n
51
MET
51
A
LYS
52
n
52
LYS
52
A
VAL
53
n
53
VAL
53
A
GLN
54
n
54
GLN
54
A
ASN
55
n
55
ASN
55
A
GLN
56
n
56
GLN
56
A
GLU
57
n
57
GLU
57
A
LYS
58
n
58
LYS
58
A
ALA
59
n
59
ALA
59
A
GLU
60
n
60
GLU
60
A
GLU
61
n
61
GLU
61
A
LEU
62
n
62
LEU
62
A
TYR
63
n
63
TYR
63
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
HIS
2
A
O
HIS
2
A
N
LYS
24
A
N
LYS
24
A
O
GLU
19
A
O
GLU
19
A
N
LYS
35
A
N
LYS
35
1
A
SER
27
-150.37
-57.84
1
A
SER
30
-172.13
56.54
1
A
PRO
50
-53.72
108.54
1
A
LYS
52
-101.72
-163.98
1
A
GLN
54
-62.84
73.06
1
A
ASN
55
-174.88
-41.29
1
A
GLU
60
-80.23
43.51
refinement
AMBER
HEREGULIN-ALPHA EPIDERMAL GROWTH FACTOR-LIKE DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE
1
Y
N
A
GLU
8
A
GLU
8
HELX_P
A
PHE
13
A
PHE
13
1
1
6
disulf
2.057
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
20
A
SG
CYS
20
1_555
disulf
2.045
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
34
A
SG
CYS
34
1_555
disulf
2.039
A
CYS
36
A
SG
CYS
36
1_555
A
CYS
45
A
SG
CYS
45
1_555
GROWTH FACTOR
GROWTH FACTOR
NRG1_HUMAN
UNP
1
1
Q02297
SERKEGRGKGKGKKKERGSGKKPESAAGSQSPALPPRLKEMKSQESAAGSKLVLRCETSSEYSSLRFKWFKNGNELNRKN
KPQNIKIQKKPGKSELRINKASLADSGEYMCKVISKLGNDSASANITIVESNEIITGMPASTEGAYVSSESPIRISVSTE
GANTSSSTSTSTTGTSHLVKCAEKEKTFCVNGGECFMVKDLSNPSRYLCKCQPGFTGARCTENVPMKVQNQEKAEELYQK
RVLTITGICIALLVVGIMCVVAYCKTKKQRKKLHDRLRQSLRSERNNMMNIANGPHHPNPPPENVQLVNQYVSKNVISSE
HIVEREAETSFSTSHYTSTAHHSTTVTQTPSHSWSNGHTESILSESHSVIVMSSVENSRHSSPTGGPRGRLNGTGGPREC
NSFLRHARETPDSYRDSPHSERYVSAMTTPARMSPVDFHTPSSPKSPPSEMSPPVSSMTVSMPSMAVSPFMEEERPLLLV
TPPRLREKKFDHHPQQFSSFHHNPAHDSNSLPASPLRIVEDEEYETTQEYEPAQEPVKKLANSRRAKRTKPNGHIANRLE
VDSNTSSQSSNSESETEDERVGEDTPFLGIQNPLAASLEATPAFRLADSRTNPAGRFSTQEEIQARLSSVIANQDPIAV
176
238
1HAF
1
63
Q02297
A
1
1
63
3
anti-parallel
anti-parallel
A
HIS
2
A
HIS
2
A
LYS
5
A
LYS
5
A
GLU
19
A
GLU
19
A
LYS
24
A
LYS
24
A
TYR
32
A
TYR
32
A
LYS
35
A
LYS
35
1
P 1